Case Report: An Unusual Case Of Guillain-Barré Syndrome
Keywords:
MedicineReferences
1 Ropper AH. The Guillain-Barré Syndrome. N Engl J Med 1992;326:1130-1136.
2 Visser LH, Schmitz PIM, Meulstee J et al. Prognostic factors of Guillain-Barré Syndrome after intravenous immunoglobulin or plasma exchange. Neurology 1999;53:598-604.
3 Rees JH, Soudain SE, Gregson NA, Hughes RA. Campylobacter jejuni infection and Guillain-Barré Syndrome. N Engl J Med 1995;333:1415-1417.
4 Honavar M, Tharakan JHJ, Hughes RAC et al. A clinico-patho- logical study of the Guillain-Barré Syndrome: nine cases and lit- erature review. Brain 1991;114:1245-1269.
5 Hahn AF. Seminar on Guillain-Barré Syndrome. Lancet 1998;352:635-641.
6 Murphy SF. Guillain-Barré Syndrome - have your choice. Irish Medical Journal 1997;90, 290.
7 Barohn RJ, Saperstein DS. Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy. Seminars in Neurology 1998;18(1):49-61.
8 Ho TW, Li CY, Cornblath DR et al. Patterns of recovery in Guillain-Barré Syndrome. Neurology 1997;48:695-700.
9 Willison HJ, O’Hanlon GM. The immunopathogenesis of Miller Fisher Syndrome. J Neuroimmunol 1999;100:3-13.
10 Odaka M, Yuki N, Hirata K. Anti-GQ1b IgG antibody syn- drome: clinical and immunological range. J Neurol Neurosurg Psychiatry 2001;70:50-55.
11Mahalati K, Dawson RB et al. Characteristics of 73 patients, 1984-1993, treated by plasma exchange for Guillain-Barré Syndrome. J Clin Apheresis 1997;12(3):116-121.
12 Shah M, Weinberger M. Rapid recovery of a child with Guillain-Barré Syndrome using intravenous immunoglobulins. J La State Med Soc 1998;150(11):553-557.
2 Visser LH, Schmitz PIM, Meulstee J et al. Prognostic factors of Guillain-Barré Syndrome after intravenous immunoglobulin or plasma exchange. Neurology 1999;53:598-604.
3 Rees JH, Soudain SE, Gregson NA, Hughes RA. Campylobacter jejuni infection and Guillain-Barré Syndrome. N Engl J Med 1995;333:1415-1417.
4 Honavar M, Tharakan JHJ, Hughes RAC et al. A clinico-patho- logical study of the Guillain-Barré Syndrome: nine cases and lit- erature review. Brain 1991;114:1245-1269.
5 Hahn AF. Seminar on Guillain-Barré Syndrome. Lancet 1998;352:635-641.
6 Murphy SF. Guillain-Barré Syndrome - have your choice. Irish Medical Journal 1997;90, 290.
7 Barohn RJ, Saperstein DS. Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy. Seminars in Neurology 1998;18(1):49-61.
8 Ho TW, Li CY, Cornblath DR et al. Patterns of recovery in Guillain-Barré Syndrome. Neurology 1997;48:695-700.
9 Willison HJ, O’Hanlon GM. The immunopathogenesis of Miller Fisher Syndrome. J Neuroimmunol 1999;100:3-13.
10 Odaka M, Yuki N, Hirata K. Anti-GQ1b IgG antibody syn- drome: clinical and immunological range. J Neurol Neurosurg Psychiatry 2001;70:50-55.
11Mahalati K, Dawson RB et al. Characteristics of 73 patients, 1984-1993, treated by plasma exchange for Guillain-Barré Syndrome. J Clin Apheresis 1997;12(3):116-121.
12 Shah M, Weinberger M. Rapid recovery of a child with Guillain-Barré Syndrome using intravenous immunoglobulins. J La State Med Soc 1998;150(11):553-557.
Downloads
Published
2001-01-01
How to Cite
Beddy, P., & Lynch, T. (2001). Case Report: An Unusual Case Of Guillain-Barré Syndrome. Trinity Student Medical Journal , 2(1), Page 6–7. Retrieved from https://ojs.tchpc.tcd.ie/index.php/tsmj/article/view/1897
Issue
Section
Case Reports
License
Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
Provided they are the owners of the copyright to their work, authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository, in a journal or publish it in a book), with an acknowledgement of its initial publication in this journal.
